Evidence map›Paper›PMID 37964869›Full record

ArticleFrontiers in pharmacology2023

Do disease-modifying antirheumatic drugs and non-steroidal anti-inflammatory drugs increase the burden on ankylosing spondylitis patients with mild-moderate COVID-19? evidence from a retrospective cohort study.

Yan Li, Zhengyuan Hu, Yufei Guo, Zheng Zhao, Kunpeng Li, Xiuru Wang, Jie Zhang, Dongfeng Liang, Jianglin Zhang, Xiaoyue Hu and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Yan Li *Department of Rheumatology and Immunology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Zhengyuan Hu *Department of Rheumatology and Immunology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Yufei GuoDepartment of Rheumatology and Immunology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Zheng ZhaoDepartment of Rheumatology and Immunology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Kunpeng LiDepartment of Rheumatology and Immunology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Xiuru WangDepartment of Rheumatology and Immunology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Jie ZhangDepartment of Rheumatology and Immunology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Dongfeng LiangDepartment of Rheumatology and Immunology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Jianglin ZhangDepartment of Rheumatology and Immunology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Xiaoyue HuSchool of Social Development and Public Policy, Fudan University, Shanghai, China.
Jian ZhuDepartment of Rheumatology and Immunology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Feng HuangDepartment of Rheumatology and Immunology, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Chinese PLA General Hospital · CNFudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ankylosing spondylitiscohort studycoronavirus disease 2019 (COVID-19)DMARDs (synthetic)NSAID (non-steroidal anti-inflammatory drug)TNF-inhibitor

Identifiers

PMID37964869
PMCPMC10642246
OpenAlexW4388100292

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.